Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine

Subjects with depressive episodes will be recruited to undergo a brief 2 week course of IV infusions of ketamine in combination with cognitive behavioral therapy for 8 weeks.

Topic Depression
Compound Ketamine
Country United States of America
Visit trial
Status Completed
Results Published
Start date 01 February 2015
End date 01 October 2016
Chance of happening 100%
Phase Phase I
Design Open
Type Interventional
Generation First
Participants 16
Sex All
Age 18- 65
Therapy No

Trial Details

Twelve subjects with current diagnosis of depressive episode will be recruited to undergo a brief course of 4 intravenous infusions of ketamine, given twice weekly for two weeks in combination with CBT, given twice weekly. The CBT course will be 16 total sessions (given over 8 weeks), will begin the day following the initial ketamine infusion, and will be performed by a therapist who has successfully completed extensive training at the Beck Institute for Cognitive Therapy and Research and has experience with similar studies. Homework assignments will include thought records and activity charts which are used in standard practice to facilitate CBT interventions.

NCT Number NCT02289248

Sponsors & Collaborators

Yale University
The Yale Psychedelic Science Group was established in 2016.

American Academy of Child Adolescent Psychiatry
This company doesn't have a full profile yet, it is linked to a clinical trial.

Measures Used

Montgomery-Asberg Depression Rating Scale
A ten-item diagnostic questionnaire used to measure the severity of depressive symptoms in patients with mood disorders.

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.